Clinical Trial Update: Topical Imiquimod for Bowen's Disease of the Head and Neck [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update indicating ongoing Phase 2 and Phase 3 studies evaluating topical imiquimod for Bowen's disease of the head and neck.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bowen Disease

Drugs mentioned

• Imiquimod (imiquimod)

Snippet

Sponsor: Brooke Army Medical Center | Conditions: Bowens Disease | Phase 2, Phase 3 | Status: UNKNOWN